Effect of magnesium sulfate on the rate of epilepsy and cesarean section

Assessment of the magnesium sulfate effect on the frequency of epilepsy and cesarean section in women with pre- eclampsia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016052111020N5

Enrollment

500

Registered

2016-10-27

Start date

2016-11-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preeclampsia. Gestational Moderate pre-eclampsia

Interventions

Intervention 1: Intervention group: 4 grams of magnesium sulfate of 50% solution in 200 cc ringer serum is infused during 20 minuets and then 2 grams magnesium sulfate per hour is injected intravenou

Treatment - Drugs

Intervention group: 4 grams of magnesium sulfate of 50% solution in 200 cc ringer serum is infused during 20 minuets and then 2 grams magnesium sulfate per hour is injected intravenously and continue

Control group: Distilled water is infused the same as the first group dosage.

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: mild pre- eclampsia; blood pressure between 130-90/ 150-105 mmhg/ mild protein urea Exclusion criteria: sever pre- eclampsia; blurred vision; sever protein urea; oligurea; impaired liver enzyme; previous cesarean

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Epilepcy. Timepoint: After delivery up to 24 hours. Method of measurement: Observational.;Cesarean section. Timepoint: During delivery. Method of measurement: Observational.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Maryam Khooshide

Zahedan Uviversity of Medical Sciences

khooshide@tums.ac.ir+98 54 3339 5796

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026